Ligand Pharmaceuticals

LGND

NASDAQHealth Care

Income Statement

Total Revenue$167.13M

Gross Profit$156.06M

Operating Income$-22.61M

EBITDA$42.92M

EBIT$5.55M

Pre-tax Income$184.88M

Net Income$-4.03M

Cash Equivalent$51.04M

Total Debt$7.05M

Book Value$813.33M

Book Value Per Share44.67

Return on Equity (ROE)-49.00%

Return on Assets (ROA)-43.00%

Return on Invested Capital (ROI)-49.00%

Net Profit Margin-2.41%

Current Ratio8.97

Quick Ratio8.54

Long-Term Debt / Equity0.00